Trial Search Results

Feasibility Neurocognitive Outcome After Transplant

This pilot study will primarily be evaluated by feasibility and adherence to an iPad-based neurocognitive intervention program. It will secondarily be evaluated by performance on the neurocognitive testing post-transplant and change in performance in subsequent years.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Behavioral: Cognitive rehabilitation program




Inclusion Criteria:

   - All patients must have a histologic or cytological diagnosis of ALL treated with stem
   cell transplantation. There are no restrictions on prior therapy.

   - Patients must be between the ages of 6 years and 21 years of age (inclusive), but
   there will be no discrimination based on gender, race, creed, or ethnic background.
   The age limits are set at 6 years of age in order to ensure that patients will be able
   to participate in these specific cognitive rehabilitation tasks. ECOG/KPS will not be

   - Patient and/or parents/guardians as appropriate must sign an informed consent, be
   mentally responsible, able to understand and willing to sign a written informed

Exclusion Criteria:

   - Subjects with significant concurrent medical complications that in the judgment of the
   Principal Investigator(s) could affect the patient's ability to complete the planned
   trial. There are no therapy restrictions or restrictions regarding the use of other
   Investigational Agents.

   - Pregnant patients will be excluded.

Ages Eligible for Study

6 Years - 21 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Claire Baniel